RDHL
Redhill Biopharma Ltd
NASDAQ: RDHL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.04
+0.00% today
Updated 2026-04-29
Market cap
$5.27M
P/E ratio
0.00
P/S ratio
0.55x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$1 – $3
Volume
0.0M
Redhill Biopharma Ltd (RDHL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.63M | $-4.69M | $-6.79M | $-8.44M | $-12.23M | $-17.83M | $-28.26M | $-44.77M | $-34.46M | $-40.75M | $-48.58M | $-65.05M | $-29.18M | $-35.82M | $-9.37M | $-9.65M |
| Capital expenditures | $1.11M | $181000.00 | $108000.00 | $224000.00 | $1.10M | $1.63M | $120000.00 | $1.18M | $58000.00 | $203000.00 | $53.77M | $115000.00 | $198000.00 | $11000.00 | $9000.00 | $5000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $80000.00 | $2.86M | $1.65M | $1.25M | $1.75M | $1.36M | $1.68M | $2.23M | $2.68M | $3.03M | $4.20M | $10.21M | $5.67M | $1.65M | $665000.00 | $457000.00 |
| Free cash flow | $-2.74M | $-4.87M | $-6.90M | $-8.66M | $-13.33M | $-19.46M | $-28.38M | $-45.95M | $-34.52M | $-40.95M | $-102.35M | $-65.16M | $-29.38M | $-35.83M | $-9.38M | $-9.66M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |